- •Foreword
- •Preface
- •Contents
- •Contributors
- •Acronyms
- •1.1 Introduction
- •1.2 Epidemiology
- •1.3 Risk Factors
- •1.3.1 Duration of Diabetes Mellitus
- •1.3.2 Glycemic Control
- •1.3.3 Hypertension
- •1.3.4 Ethnic Differences
- •1.3.5 Obesity
- •1.3.6 Socioeconomic Status
- •1.3.7 Other Risk Factors
- •1.4 Pathophysiology
- •Conclusion
- •References
- •2: Non-proliferative Diabetic Retinopathy
- •2.1 Clinical Overview
- •2.1.1 Clinical Findings
- •2.1.2 Classification of NPDR
- •2.1.3 Atypical Forms of NPDR
- •2.2 Diagnostic Tools
- •2.2.1 Telemedicine
- •2.2.2 Fundus Photography
- •2.2.3 Fluorescein Angiography
- •2.2.4 Ultrasonography
- •2.2.5 Optical Coherence Tomography
- •2.2.6 Adaptive Optics Scanning Laser Ophthalmoscope
- •2.2.7 Multifocal Electroretinogram
- •2.2.8 Pattern Visual Evoked Potentials
- •2.2.9 Other Diagnostic Tools
- •2.3 Present Therapies
- •2.3.1 Primary Interventions
- •2.3.1.1 Glycemic Control
- •2.3.1.2 Blood Pressure Control
- •2.3.1.3 Lipid-Lowering Therapy
- •2.3.2 Secondary Interventions
- •2.3.2.1 Protein Kinase C Inhibitors
- •2.4 Evolving Algorithms
- •2.4.1 Screening
- •2.4.2 Laser Photocoagulation
- •2.5 New Frontiers
- •References
- •3: Diabetic Macular Edema
- •3.1 Clinical Overview
- •3.1.1 Clinical Findings
- •3.1.2 Biomicroscopic Classification of DME
- •3.2 Diagnostic Tools
- •3.2.1 Fluorescein Angiography
- •3.2.2 Optical Coherence Tomography
- •3.2.3 Fundus Photography
- •3.2.4 Microperimetry
- •3.2.5 Multifocal Electroretinogram
- •3.2.6 Other Imaging Under Investigation
- •3.3 Present Therapies
- •3.3.1 Laser Photocoagulation
- •3.3.2 Intravitreal Pharmacotherapies
- •3.3.2.1 Intravitreal Steroids
- •3.3.2.2 Intravitreal Anti-VEGF
- •3.3.3 Pars Plana Vitrectomy
- •3.4 Evolving Algorithms
- •3.4.1 Therapeutic Algorithms
- •3.4.2 Factors Associated with Favorable Response to the Therapy
- •3.4.3 Treatment of DME Associated with Macular Ischemia
- •3.5 New Frontiers
- •References
- •4: Proliferative Diabetic Retinopathy
- •4.1 Clinical Overview
- •4.1.1 Clinical Findings
- •4.1.2 Classification of PDR
- •4.2 Diagnostic Tools
- •4.2.1 Fluorescein Angiography
- •4.2.2 Fundus Photography
- •4.2.3 Ultrasonography
- •4.2.4 Optical Coherence Tomography
- •4.2.5 Perimetry
- •4.2.6 Further Diagnostic Tools
- •4.3 Present Therapies
- •4.3.1 Panretinal Laser Photocoagulation
- •4.3.2 Intravitreal Injections
- •4.3.2.1 Intravitreal Steroids
- •4.3.2.2 Intravitreal Anti-VEGF Agents
- •4.4 Evolving Algorithms
- •4.5 New Frontiers
- •References
- •5.1 Introduction
- •5.2 Pathophysiology
- •5.3 Neovascular Glaucoma
- •5.4 Tractional Retinal Detachment
- •5.5 Treatment
- •5.5.1 Panretinal Laser Photocoagulation
- •5.5.2 Pars Plana Vitrectomy and Endophotocoagulation
- •5.5.4 Silicone Oil Tamponade
- •5.5.4.1 Viscodissection
- •Conclusion
- •References
128 |
F. Bandello et al. |
|
|
a |
b |
c
Fig. 4.5 Young female with poor metabolic control and no adherence to the routinely ophthalmological screening, who complains reduced visual acuity and left eye pain. Complete ophthalmic examination showed a best corrected visual acuity of counting fingers and neovascular glaucoma. (a) Fundus photography of the posterior pole clearly shows few hard exudates (arrowhead) and hemorrhages at the posterior pole, associated to whiteness of the inferior temporal artery (arrow), from non-perfusion and hyalinization. (b) FA reveals massive hypo-fluorescence of the periphery due to confluent areas of retinal non-perfusion and macular ischemia. A mild hyper-fluorescence from breakdown of the blood-retinal barrier is seen in the inter-papillomacular area. (c) OCT horizontal scan shows the presence of subretinal fluid located in the nasal area, juxtafoveal hard exudates (asterisk), reduced retinal thickness temporally to the fovea and epiretinal membrane, with mild vitreomacular traction
4.1.2Classification of PDR
The classification proposed by the Diabetic Retinopathy Study (DRS) in 1981 provided four different levels of severity of PDR, including mild, moderate, high risk, and advanced PDR (Table 4.1) [16]. The DRS defined the concept of high-risk PDR, which is characterized by one or more of the following characteristics: any NVD situated on or within one optic disk area, in association with vitreous or preretinal hemorrhage; moderate to severe NVD (defined as greater than or equal to a size included between 0.24 and 0.33 optic disk areas) in the absence of preretinal or vitreous hemorrhage; and NVE of 0.5 disk area more associated with vitreous or preretinal hemorrhage (Fig. 4.6). Neovascularization of the iris has not been included between the high-risk group defined by the DRS. The identification of the high-risk severity level of PDR revealed a significant role in the prognosis of the treatment with panretinal photocoagulation (PRP).
4 Proliferative Diabetic Retinopathy |
129 |
|
|
|
|
Table 4.1 Modified from the DRS classification of PDR |
|
|
Severity level |
Clinical findings |
|
Mild PDR |
NVE in one or more quadrants with less than 0.5 optic disk areas |
|
Moderate PDR |
NVE in one or more quadrants with 0.5 or more optic disk areas |
|
|
NVD included between 0.24 and 0.33 optic disk area |
|
High-risk PDR |
NVD located on or within one optic disk area plus vitreous or preretinal |
|
|
hemorrhage |
|
|
Moderate to severe NVD (greater than or equal to a size included between |
|
|
0.24 and 0.33 optic disk area) without preretinal or vitreous hemorrhage |
|
|
NVE of 0.5 disk area more plus vitreous or preretinal hemorrhage |
|
Advanced PDR |
Fundus partially or completely obscured by vitreous hemorrhage |
|
|
New vessels ungradable in at least one field |
|
|
Retinal detachment at the center of the macula |
|
Fig. 4.6 High-risk PDR associated with complete disorganization of the retinal vasculature: massive NVD (arrow), intraretinal microvascular abnormalities (arrowhead), preretinal hemorrhages, extensive area of capillary non-perfusion, and amputation of the capillary network at the posterior pole
Table 4.2 Modified from the AAO |
Severity level |
Clinical findings |
definition of PDR |
PDR |
One or more of the following findings: |
|
||
|
|
Neovascularization |
|
|
Vitreous or preretinal hemorrhage |
In the later proposed International Clinical Diabetic Retinopathy Disease Severity Scale, proposed by the American Academy of Ophthalmology (AAO) in 2001, the PDR scheme has been widely simplified (Table 4.2) [17]. In this classification, PDR is defined by the presence of one or more of the following clinical findings, including any type of neovascularization and vitreous or preretinal hemorrhage. The authors did not identify a high-risk sublevel of PDR, because significant rates of progression and complications are possibly expected at any stage of PDR.
